User profiles for Sanghita Sarkar

Sanghita Sarkar

The University of Alabama at Birmingham
Verified email at uabmc.edu
Cited by 293

[HTML][HTML] Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection

…, S Boppana, MD Perez, S Sarkar… - The Journal of …, 2021 - Am Soc Clin Investig
Ongoing observational clinical research has prioritized understanding the human immune
response to SARS-CoV-2 during the coronavirus disease 2019 (COVID-19) pandemic. …

[HTML][HTML] Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responses

JK Files, S Sarkar, TR Fram, S Boppana, S Sterrett… - JCI insight, 2021 - ncbi.nlm.nih.gov
A subset of COVID-19 patients exhibit post-acute sequelae of COVID-19 (PASC), but little is
known about the immune signatures associated with these syndromes. We investigated …

[PDF][PDF] Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters

…, FS Oladunni, A Deshpande, M Basu, S Sarkar… - Cell Reports …, 2021 - cell.com
SARS-CoV-2 infection results in viral burden in the respiratory tract, enabling transmission
and leading to substantial lung pathology. The 1212C2 fully human monoclonal antibody was …

[HTML][HTML] Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing …

…, A Deshpande, A Loos, C Ye, M Basu, S Sarkar… - PLoS …, 2022 - journals.plos.org
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) marks the third novel β-coronavirus
to cause significant human mortality in the last two decades. Although vaccines …

[HTML][HTML] IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine

S Sarkar, MS Piepenbrink, M Basu, J Thakar… - Vaccine, 2019 - Elsevier
Induction of a sustained and broad antibody (Ab) response is a major goal in developing a
protective HIV-1 vaccine. DNA priming alone shows reduced levels of immunogenicity; …

Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody

…, A Desphande, A Loos, C Ye, M Basu, S Sarkar… - bioRxiv, 2022 - biorxiv.org
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) marks the third novel β-coronavirus
to cause significant human mortality in the last two decades. Although vaccines …

Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN. 1 and other variants

…, AM Khalil, A Chang, A Mostafa, M Basu, S Sarkar… - bioRxiv, 2024 - biorxiv.org
SARS-CoV-2 continues to be a public health burden, driven in-part by its continued antigenic
diversification and resulting emergence of new variants. While increasing herd immunity, …

Innate Immune Response To Yersinia Pestis

S Sarkar - 2015 - commons.und.edu
… This dissertation, submitted by Sanghita Sarkar in partial fulfillment of the requirements for
the Degree of Doctor of Philosophy from the University of North Dakota, has been read by the …

[HTML][HTML] CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques

S Sarkar, DA Spencer, P Barnette, S Pandey… - Frontiers in …, 2021 - frontiersin.org
Induction of broadly neutralizing antibodies (bNAbs) is a major goal for HIV vaccine development.
HIV envelope glycoprotein (Env)-specific bNAbs isolated from HIV-infected individuals …

Cloning and functional testing of rhesus macaque (Macaca mulatta) IL‐9 and IL‐33

S Sarkar, AJ Hessell, NL Haigwood… - Journal of medical …, 2020 - Wiley Online Library
Background IL‐9 and IL‐33 can profoundly influence immune responses. As a necessary
first step toward defining their impact in the rhesus macaque model, we confirmed their …